Healio Minute Podcast, Leukemia Edition: Top Headlines - Week of May 29, 2023
In this edition, cross-border partnership takes on survival gap for children with leukemia; ‘paradigm shift’ in transfusion-dependent myelodysplastic syndrome; FDA approves Ayvakit for mastocytosis and more.
Read the full coverage here:
Cross-border partnership takes on ‘huge survival gap’ among children with leukemia
Luspatercept ‘a paradigm shift’ in transfusion-dependent myelodysplastic syndrome
FDA approves Ayvakit for indolent systemic mastocytosis
Novel leukemia treatment signals ‘new era in CAR T-cell therapy’
Functional precision medicine-guided approach benefits pediatric patients with cancer
References:
Acanda de la Rocha AM, et al. Abstract LB358. Presented at: American Association of Cancer Research Annual Meeting; April 14-19, 2023; Orlando.
Appelbaum J, et al. Abstract 3092. Presented at: American Society of Gene & Cell Therapy Annual Meeting; May 16-20, 2023; Los Angeles.
Aristizabal P, et al. Abstract 1502. Presented at: ASCO Annual Meeting; June 2-6, 2022; Chicago.
Garcia-Manero G, et al. Abstract 7003. Scheduled for presentation at: ASCO Annual Meeting; June 2-6, 2022; Chicago.
